Copyright © 2007, European Society of Cardiology
Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat
Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
* Corresponding author. Department of Physiology, Maastricht University, PO BOX 616, 6200MD Maastricht, The Netherlands. Tel.: +31433881202; fax: +31433884166. m.allessie{at}fys.unimaas.nl
Objective In electrically remodeled atria the effect of blockers of the delayed rectifier K+ current IKr on repolarization is reduced, whereas the efficacy of ‘early’ class III drugs (IKur/Ito/IKach blockers) is enhanced. We evaluated the electrophysiological and antifibrillatory effects of AVE0118, dofetilide, and ibutilide (alone and in combination) on persistent atrial fibrillation (AF) in the goat.
Methods and results The effects of separate and combined administration of AVE0118, dofetilide, and ibutilide were determined before and after 48 h of AF. AVE0118 alone markedly prolonged the atrial refractory period (400 ms cycle length) (AERP400) before and after 48 h of AF. The prolongation of AERP400 by dofetilide and ibutilide, respectively, was reduced by AF from 22±2 to 7±2 ms (p<0.01) and 25±5 to 5±2 ms (p=0.01). Pre-treatment with AVE0118 restored the prolongation of AERP400 by dofetilide or ibutilide (to 20±3 and 30±6 ms; p<0.01). This effect was atrial specific since the QT-interval was not changed. The antifibrillatory action was evaluated in 10 goats that were in persistent AF for 57±7 days. Dofetilide (20 µg/kg/h) or ibutilide (4 mg/h) alone restored sinus rhythm in only 20% of the animals. AVE0118 (1, 3, and 10 µg/kg/h) terminated AF in 11, 30, and 60%, respectively. Additional infusion of IKr blockers caused an additional number of cardioversions, resulting in a final cardioversion rate of 56, 80, and 100%, respectively. AVE0118 alone prolonged the AF cycle length (AFCL) while the conduction velocity during AF (CVAF) remained unchanged (70±1 vs. 68±2 cm/s; p=0.3). Addition of dofetilide or ibutilide caused a synergistic increase in AFCL and a slight increase in CVAF to 74±1 cm/s (p<0.001). The length of the reentrant trajectories increased from 7.6±0.3 (control) to 11.6±0.5 cm after AVE0118 alone (p<0.001) and 14.8±0.8 cm after addition of dofetilide or ibutilide (p<0.001).
Conclusions In electrically remodeled atria, blockade of IKur/Ito/IKAch restored the class III action of IKr blockers. Persistent AF could be effectively cardioverted by infusion of a combination of AVE0118 and dofetilide or ibutilide. This antifibrillatory action was associated with an almost twofold lengthening of the intra-atrial pathways for reentry.
KEYWORDS antiarrhythmia agents; electrophysiology; atrial fibrillation; K-channel
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. M. Maleckar, J. L. Greenstein, W. R. Giles, and N. A. Trayanova K+ current changes account for the rate dependence of the action potential in the human atrial myocyte Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1398 - H1410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al. Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation' Europace, July 1, 2009; 11(7): 860 - 885. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. John Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF' Eur. Heart J., June 17, 2009; (2009) ehp235v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Geller, K. Egstrup, P. Kulakowski, M. Rosenqvist, M. A. Jansson, A. Berggren, N. Edvardsson, P. Sager, and H. J. Crijns Rapid Conversion of Persistent Atrial Fibrillation to Sinus Rhythm by Intravenous AZD7009 J. Clin. Pharmacol., March 1, 2009; 49(3): 312 - 322. [Abstract] [Full Text] [PDF]
|
|